Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessWhat to Expect From McCormick & Company’s Upcoming Q2 Earnings?

What to Expect From McCormick & Company’s Upcoming Q2 Earnings?

Add to Favorite
Added to Favorite


Analyst at Deutsche Bank provided their views on McCormick & Company (NYSE:MKC) ahead of the company’s upcoming Q2/22 earnings, which are expected to be reported on June 29.
While the company has demonstrated solid execution and momentum throughout the pandemic, the analysts believe the top-and bottom-line delivery will be incrementally tougher moving forward as consumers shift towards value brands and cost headwinds linger throughout 2022 and into 2023.
Furthermore, with inflation pressures continuing to escalate in recent months (alongside volatility in China and more adverse FX headwinds), the company is likely to see its 2022 profit skew further towards the second half of its fiscal year than previously planned. That said, the analysts’ base case remains that the company will still largely reiterate its full-year outlook (if now likely skewed to the low end of its $3.17-$3.22 EPS range).
The analysts reduced their price target to $91 from $99, while keeping their hold rating unchanged.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Thermo Fisher Scientific Reports Better Than Expected Q1 Results

Thermo Fisher Scientific (NYSE:TMO) announced its first-quarter earnings and...

Humana Drops 5 percent Despite Q1 Beat

Humana (NYSE:HUM) saw its shares drop by around 5%...

AT&T Reports Q1 EPS Beat, But Revenues Missed

AT&T (NYSE:T) reported its first-quarter earnings that exceeded analyst...